Skip to content

A prospective clinical trial of a multidisciplinary electronic cardiovascular prevention programme

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN23940498
Enrollment
350
Registered
2007-03-06
Start date
2007-03-23
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prevention of Cardiovascular diseases Circulatory System Cardiovascular diseases

Interventions

1. Medical interventions by GPs: determination of cardiovascular risk using a new computer tool, medical interventions aimed at medical risk factors (e.g. hypertension, high blood glucose level, high

Sponsors

De Onderlinge Ziekenkas (Belgium)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 25-65 2. Insured by the Onderlinge Ziekenkas, insuring for guaranteed income in case of illness for self-employed 3. Inhabitants of Limburg

Exclusion criteria

Exclusion criteria: People with a high cardiovascular risk are not excluded from the PreCardio-study, given the constant supervision GPs and a cardiologist involved in PreCardio. However, high risk participants are advised not to take part in certain rigourous training schemes available to the participants of the study

Design outcomes

Secondary

MeasureTime frame
1. The incidence of cardiovascular events 2. Number and total costs of cardiovascular events leading to loss of productivity 3. The effects of medical and behavioural interventions on psychological constructs as stage of change, attitude towards behaviour, self-identity, perceived behavioural control, autonomous motivation, intention 4. The effects of medical and behavioural interventions on Health Related Quality of Life 5. The effects of social support on health related behaviour (physical activity, fat and fibre intake and smoking behaviour) and psychological constructs (stage of change, attitude towards behaviour, self-identity, perceived behavioural control, autonomous motivation, intention) 6. A cost-effectiveness analysis of the medical and behavioural interventions using incremental cost-effectiveness ratios

Primary

MeasureTime frame
1. The effects of medical and behavioural interventions on medical parameters such as systolic blood pressure, diastolic blood pressure, total blood cholesterol level, blood glucose level (HbA1c), overweight and obesity, BMI 2. The effects of medical and behavioural interventions on health related behaviour such as physical activity; fat; fruit and vegetable intake; and smoking behaviour 3. The effects of medical and behavioural interventions on overall cardiovascular risk mediated by changes in medical and/or behavioural risk factors 4. The proportion of study participants with a 10% reduction in systolic blood pressure with participants with hypertension 5. The proportion of study participants with a 10% reduction in diastolic blood pressure with participants with hypertension 6. The proportion of study participants with a 10% reduction in total cholesterol with patients with hypercholesterol 7. The proportion of study participants with a 10% reduction in HB1Ac with initial HB1Ac >7% (high risk) 8. The proportion study participants with a 10% reduction in weight with initial BMI >25 kg/m²

Countries

Belgium

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 23, 2026